v3.26.1
Unaudited Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Income Statement [Abstract]        
Revenue $ 0 $ 0 $ 0 $ 0
Operating expenses:        
Research and development 10 (14) 59 8
General and administrative 828 800 1,892 1,636
Restructuring and other charges 174 (9) 380 31
Total operating expenses 1,012 777 2,331 1,675
Loss from operations (1,012) (777) (2,331) (1,675)
Other income:        
Interest and investment income 120 181 248 369
Change in fair value of purchase warrant liability 349 67 2,221 1,094
Total other income, net 469 248 2,469 1,463
Net income (loss) $ (543) $ (529) $ 138 $ (212)
Net income (loss) per share - basic $ (0.04) $ (0.04) $ 0.01 $ (0.02)
Net income (loss) per share - diluted $ (0.04) $ (0.04) $ 0.01 $ (0.02)
Weighted-average common shares - basic 12,418,592 12,319,147 12,406,266 12,301,476
Weighted-average common shares - diluted 12,418,592 12,319,147 12,407,049 12,301,476
Comprehensive income (loss):        
Net income (loss) $ (543) $ (529) $ 138 $ (212)
Comprehensive income (loss) $ (543) $ (529) $ 138 $ (212)